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PRECLINICAL STUDIES
emporary Pulmonary Stent Placement
s Emergency Treatment of Pulmonary Embolism
irst Experimental Evaluation
homas Schmitz-Rode, MD,* Rajeev Verma, MD,† Joachim G. Pfeffer,* Ralf-Dieter Hilgers, PHD,‡
olf W. Günther, MD†
achen, Germany
OBJECTIVES We aimed to evaluate the performance of a newly designed temporary stent device as a
percutaneous emergency treatment of pulmonary embolism.
BACKGROUND If thrombolysis is contraindicated or recanalization by thrombolysis delayed in patients with
severe pulmonary embolism who are threatened by acute circulatory failure, percutaneous
temporary pulmonary stent placement may represent an additional option before surgical
embolectomy is considered.
METHODS The newly designed temporary pulmonary stent is made from woven Nitinol and has a distal
blunt end and a proximal crimped end, which is firmly fixed to a 0.035-inch guidewire. It is
delivered through a 9.5-F polytetrafluoroethylene sheath using a pusher tube. Stent
placement and removal were examined in 9 anesthetized sheep with experimentally induced
pulmonary embolism. Hemodynamic parameters were recorded in 7 animals.
RESULTS Delivery and removal of the stent was uneventful and rapidly accomplished. Stent placement
was associated with a significant decrease in Miller angiographic index (from 11.2  3.1 to
3.8  1.9; p  0.0001), heart rate (from 139  35 beats/min to 92  11 beats/min; p 
0.0129), and mean pulmonary artery pressure (from 32  14 mm Hg to 21  14 mm Hg;
p 0.0029) and a significant increase in mean aortic pressure (from 48 14 mm Hg to 61 
8 mm Hg; p 0.0080). Autopsy revealed neither wall damage nor parenchymal hemorrhage.
CONCLUSIONS Our preliminary study proves the technical feasibility of temporary placement and removal of
a newly designed dedicated pulmonary stent to recanalize centrally located embolic occlusions
in severe pulmonary embolism. Animal experimental evaluation revealed rapid and significant
circulatory improvement after stent placement. (J Am Coll Cardiol 2006;48:812–6) © 2006
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.04.079by the American College of Cardiology Foundation
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dhe mainstay of treatment in severe pulmonary embolism
PE) is systemic thrombolytic therapy and, if thrombolysis
s foreseen to fail, surgical embolectomy (1,2). Catheter-
irected techniques, such as embolus fragmentation or
spiration, are not widely established (3,4).
Our study introduces a new percutaneous mode of
herapy that may serve as an additional option before
esorting to surgical embolectomy. We present the first
nimal experimental evaluation of a percutaneous tem-
orary stent implantation into the obstructed central
ulmonary artery as a short-term treatment that is
ntended to bridge to circulatory stabilization. The re-
ovable stent is expanded alongside the main pulmonary
mbolus to create a patent channel to provide for reper-
usion of the dependent periphery and immediate relief of
ight ventricular afterload.
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emporary pulmonary stent device. The pulmonary stent
custom-made, Helmholtz Institute, Aachen, Germany)
onsists of woven, self-expanding, shape-memory alloy wire
Nitinol; Euroflex, Pforzheim, Germany) with a maximum
xpanded diameter of 20 mm and a length of 100 mm (Fig. 1).
ts distal open end features wire U-bends and thus a smooth
rown-like edge. The proximal crimped end is firmly fixed
o a 0.035-inch highly flexible hydrophilically coated guide-
ire (Radifocus; Terumo, Tokyo, Japan). The stent device
s delivered through a pre-placed 9.5-F custom-made poly-
etrafluoroethylene (PTFE) sheath (Helmholtz Institute),
sing a 6.5-F custom-made PTFE pusher tube (Helmholtz
nstitute). The stent is deployed under fluoroscopic control
y holding the pusher tube and withdrawing the sheath.
fter placement, both sheath and pusher tube are removed,
eaving the stent with the attached floppy guidewire in
lace. For stent removal, the wire serves as a guide axis, over
hich the 9.5-F sheath is re-advanced. The stent is removed
y withdrawal into the sheath.
ulmonary embolism animal model. The pulmonary stent
evice was examined in 9 anesthetized sheep (body weight
0 to 80 kg) with experimentally induced PE (5,6). Pre-
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August 15, 2006:812–6 Temporary Pulmonary Stent Placementormed thrombi (mean weight 18.3  2.1 g) were made
rom porcine blood, which was stored at 4°C for 10 days to
ncrease thrombus consistency. One thrombus per animal
as introduced through a 32-F jugular sheath and released
t the sheath tip into the right atrium. The thrombus was
irected by perfusion through the right ventricle into the
ulmonary arterial system without disintegration, causing a
entrally located embolic occlusion of one of the main
rteries. Pulmonary angiography before and after embolus
njection was performed via right femoral venous access,
sing a standard pulmonary 7-F pigtail catheter (Grollman;
igure 1. Phases of deployment of a removable pulmonary stent for
mergency treatment of acute massive pulmonary embolism, made from
elf-expanding woven shape-memory wire (maximum expanded diameter
Abbreviations and Acronyms
AP  aortic pressure
CVP  central venous pressure
PAP  pulmonary artery pressure
PCWP  pulmonary capillary wedge pressure
PE  pulmonary embolism
PTFE  polytetrafluoroethylenep
0 mm). The attached guidewire (arrow, bottom panel) facilitates removal
y withdrawal into the 9.5-F sheath.erit Medical, South Jordan, Utah) and by producing
ngiograms in 3 standard projections.
The 9.5-F stent delivery sheath was placed in the oc-
luded pulmonary artery. The wire-mounted stent was
ushed with its proximal edge up to the tip of the delivery
heath using the coaxial pusher tube. Deployment of the
tent was observed under fluoroscopy. Final angiograms
ocumented the extent of recanalization. After the proce-
ure the stent was removed.
In all 9 animals the angiographic index was determined
fter embolus injection and pulmonary stent placement. In
he last 7 animals, the following hemodynamic parameters
ere recorded before and after embolus injection and after
tent placement: heart rate, mean pulmonary artery pressure
PAP), mean aortic pressure (AP), arterial oxygen satura-
ion, central venous pressure (CVP), and pulmonary capil-
ary wedge pressure (PCWP).
utopsy. At the completion of the trial, all subjects were
illed. After en bloc resection of heart and lungs, all cardiac
tructures, particularly the right atrium, tricuspid valve,
ight ventricle, and pulmonic valve, were inspected macro-
copically for wall damage such as perforation or hemor-
hage. Main and lobar pulmonary arteries were evaluated in
he same way, with emphasis on the treated area.
tatistics. Heart rate (beats/min), mean PAP (mm Hg),
ean AP (mm Hg), arterial oxygen saturation (%), Miller
ngiographic index, CVP (mm Hg), and PCWP (mm Hg)
ere analyzed separately using a 1-factor repeated-measures
nalysis of variance (within-subjects factor: conditions
baseline,” “embolus,” and “stent”) and linear contrasts for
he within-subjects factor. The log-likelihood criterion was
sed to specify the covariance structure (unstructured, au-
oregressive, or compound symmetry). We used a signifi-
ance level of 0.05 in this explorative evaluation. Compu-
ations were performed using the MIXED procedure of
AS version 9.0 (SAS Institute, Cary, North Carolina)
nder Windows XP (Microsoft, Redmond, Washington).
ESULTS
hrombus injection and creation of PE was successful in all
nimals, with embolic occlusion of a main or intermediate/
nterlobar pulmonary artery. Pulmonary embolization of the
njected thrombus was associated with a decrease in mean
P and arterial oxygen saturation and an increase in mean
AP, heart rate, and CVP (Table 1).
Delivery and deployment of the stent was rapidly accom-
lished. The delivery sheath could be navigated adequately
nd the stent device could be quickly placed in the occluded
ulmonary arteries of all 9 sheep by bridging the occluding
mbolus on its entire length. The average procedure time of
tent placement, including positioning of the sheath, was
3.6  7.3 min (range 14 to 38 min). Angiography after
tent placement revealed partial recanalization, with im-
roved flow in all treated main, intermediate, and lobar
ulmonary arteries (Fig. 2). Correspondingly, the Miller
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Temporary Pulmonary Stent Placement August 15, 2006:812–6ngiographic index decreased significantly (p  0.0001)
Table 1).
Heart rate (Fig. 3A) and mean PAP (Fig. 3B) increased
ignificantly from baseline to embolus (F1,6  19.55; p 
.0045; and F1,6  28.22; p  0.0018) and decreased
ignificantly from embolus to stent (F1,6  16.68; p 
.0065; and F1,6 15.94; p 0.0072). Mean AP (Fig. 3C)
ecreased from baseline to embolus (F1,6  22.98; p 
.0030) and increased from embolus to stent (F1,6  12.28;
 0.0128). The CVP differed slightly from baseline to
mbolus (F1,6  5.03; p  0.0660) but not significantly
rom embolus to stent (F1,6  1.12; p  0.3312). Although
ean arterial oxygen saturation decreased and mean PCWP
ncreased after embolus injection (and vice-versa after stent
lacement), these changes were not significant (Table 1).
In autopsy, there was no incidence of damage to either
he valves or the right ventricular and atrial endocardium in
ny of the 9 animals. Furthermore, there was no pulmonary
arenchymal hemorrhage or hemothorax. In 2 cases, slight
all hemorrhage (once in the pulmonary trunk and once in
he treated left descending pulmonary artery) was observed,
hich impressed macroscopically as nonprotruding dark
luish spots, less than 1 cm in diameter and without any
ccompanying wall tears or perforation. The 7 other cases
howed no signs of damage at all.
ISCUSSION
cute circulatory failure is the leading cause of death in
atients with acute massive PE. Prompt reduction of
ight ventricular afterload is a crucial therapeutic goal to
revent a lethal course. Thrombolysis is a widely accepted
nd implemented standard therapy of acute massive PE
1,2). Optimized strategies in surgical pulmonary embo-
ectomy are accompanied by a considerable reduction of
ortality (7). This increases significance and acceptance
f open surgery as the last resort if thrombolytic therapy
s contraindicated or poor recanalization is anticipated
wing to temporal constraints. There are very few alter-
atives to these cornerstones of therapy. Interventional
atheter-based approaches include fragmentation and
spiration techniques (3,4), with the advantage of limited
nvasiveness. However, in severe cases with extensive PE,
he degree of recanalization is limited, especially if the
able 1. Summary of Hemodynamic Measurements in 7 Sheep a
Parameter Baseline E
eart rate (beats/min) 85.87  12.73 (n  7) 138.94
ulmonary artery pressure (mm Hg) 13.48  5.30 (n  7) 31.68
ortic pressure (mm Hg) 76.61  6.93 (n  7) 47.76
entral venous pressure (mm Hg) 6.80  4.90 (n  7) 10.43
rterial oxygen saturation (%) 99.79  0.39 (n  7) 90.13
CWP (mm Hg) 5.0  2.71 (n  7) 5.09
iller angiographic index (9) 0 (n  9) 11.22
alues expressed as mean  SD.
Ddf  denominator degrees of freedom; Ndf  nominator degrees of freedom;hrombus is partly organized. fiThere are two reports in the literature (8,9) that
escribe emergent pulmonary stent placement in acute
assive PE as a last choice of therapy. In both cases,
atients with cor pulmonale were threatened by cardio-
enic shock. Bilateral implantation of self-expanding
tents created patent channels alongside the emboli and
ed to rapid circulatory stabilization due to instant recan-
lization. The principle of recanalization, the compres-
ion of the embolic occlusion material by the radial
xpansion force of a stent, is similar to the approach
resented in our experimental study.
In contrast to the cited reports, which used permanently
mplantable standard stents that were neither shape-
ptimized to the pulmonary arteries nor removable, the
resent study reports the development and first experimen-
al evaluation of a dedicated temporary pulmonary stent.
uch a stent should completely bridge and recanalize the
mbolic occlusion, and should be rapidly insertable and
emovable. To avoid “floating” of the proximal half of the
tents in the pulmonary arterial trunks (8,9), the stent
hould have an appropriate mesh flexibility to adapt to the
ransition of main and interlobar arteries. Sharp ends, as
ith the Wallstent (8), are considered to be risky, particu-
arly in cases with concomitant thrombolysis, where wall
enetration would be a likely cause of hemorrhage.
Our dedicated stent is tulip-like, with rounded ends. It
as a larger proximal end and a relatively wide mesh to
upport inflow. Stent placement and removal was fast and
traightforward. In all cases, the stent was successfully
eployed alongside the thrombus so that its upper and lower
nds lay in the patent artery.
However, there were some limitations to the present pre-
iminary study. Whereas bilateral PE is very likely, a model of
nilateral PE was used. Additionally, the clot model applied
ay not fully resemble fresh acute PE. A major limitation of
he promoted recanalization technique may be a lack of
fficacy in case of distal pulmonary artery occlusion by fresh
hrombi. Furthermore, the stents were removed approxi-
ately 30 to 60 min after placement. For the desired clinical
pplication in acute massive PE, the stent is intended to stay
n place for hours up to days, as long as is necessary for
irculatory stabilization.
onclusions. Our experimental study in 9 sheep proves a
iller Angiographic Index in 9 Sheep
lus Stent F Value (Ndf; Ddf ) p Value
74 (n  7) 92.10  11.07 (n  7) 9.79 (2; 6) 0.0129
82 (n  7) 20.71  13.68 (n  7) 17.29 (2; 6) 0.0029
69 (n  7) 61.03  7.99 (n  7) 12.01 (2; 6) 0.0080
4 (n  7) 7.71  4.02 (n  7) 5.38 (2; 6) 0.0458
34 (n  7) 96.39  4.82 (n  7) 4.00 (2; 6) 0.0789
4 (n  7) 5.71  9.27 (n  7) 0.03 (2; 6) 0.9718
7 (n  9) 3.78  1.86 (n  9) 45.23 (1; 8) 0.0001
 pulmonary capillary wedge pressurend M
mbo
 34.
 13.
 13.
 6.9
 11.
 7.2
 3.0rst decisive step of the concept and the technical feasibility
F
o
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August 15, 2006:812–6 Temporary Pulmonary Stent Placementigure 2. Pulmonary angiograms obtained in the frontal (A to D) and oblique (E) views in 1 sheep. (A) Normal baseline pulmonary angiogram. (B) Angiogram
btained after thrombus injection shows massive pulmonary embolism of the left main pulmonary artery with complete occlusion of the depending left
ulmonary arteries (arrows). (C) Fluoroscopy image after placement of the pulmonary stent (arrows) attached to the wire. (D, E) Frontal and left anterior
blique angiograms obtained by contrast injection through the stent delivery sheath after left-sided stent deployment shows considerable recanalization and
mproved perfusion of the left upper and lower lobes. Residual stenosis due to compressed embolus (arrow in E).
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Temporary Pulmonary Stent Placement August 15, 2006:812–6f temporary placement and removal of a newly designed
edicated pulmonary stent to recanalize centrally located
mbolic occlusions in severe PE. Our experimental results
how that this is a very predictable, reproducible, and rapid
echnique that achieved significant circulatory improve-
ent. Its possible role as an adjunctive emergency treatment
ption in patients with severe PE needs to be addressed in
ubsequent clinical trials.
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